Alphamab Oncology (9966.HK)

HKD 7.85

(21.52%)

Revenue Summary of Alphamab Oncology

Alphamab Oncology's latest annual revenue in 2023 was 218.77 Million CNY , up 31.12% from previous year.
Alphamab Oncology's latest quarterly revenue in 2024 Q2 was 173.56 Million CNY , down 0.0% from previous quarter.
Alphamab Oncology reported a annual revenue of 166.84 Million CNY in annual revenue 2022, up 14.26% from previous year.
Alphamab Oncology reported a annual revenue of 146.02 Million CNY in annual revenue 2021, down 0.0% from previous year.
Alphamab Oncology reported a quarterly revenue of 136.46 Million CNY for 2023 Q2, down 0.0% from previous quarter.
Alphamab Oncology reported a quarterly revenue of 218.77 Million CNY for 2023 FY, up 31.12% from previous quarter.

Annual Revenue Chart of Alphamab Oncology (2023 - 2017)

Historical Annual Revenue of Alphamab Oncology (2023 - 2017)

Year	Revenue	Revenue Growth
2023	218.77 Million CNY	31.12%
2022	166.84 Million CNY	14.26%
2021	146.02 Million CNY	0.0%
2020	- CNY	-100.0%
2019	4.99 Million CNY	779.18%
2018	-735 Thousand CNY	-160.1%
2017	1.22 Million CNY	0.0%

Year	Revenue	Revenue Growth
2024 Q2	173.56 Million CNY	0.0%
2023 Q2	136.46 Million CNY	0.0%
2023 FY	218.77 Million CNY	31.12%
2023 Q4	82.3 Million CNY	0.0%
2022 Q4	113.27 Million CNY	0.0%
2022 FY	166.84 Million CNY	14.26%
2022 Q2	53.56 Million CNY	0.0%
2021 Q2	- CNY	0.0%
2021 Q4	146.02 Million CNY	0.0%
2021 FY	146.02 Million CNY	0.0%
2020 FY	- CNY	-100.0%
2020 Q4	- CNY	0.0%
2020 Q2	- CNY	0.0%
2019 FY	4.99 Million CNY	779.18%
2019 Q4	2.43 Million CNY	0.0%
2019 Q2	2.55 Million CNY	0.0%
2019 Q1	- CNY	100.0%
2018 Q1	- CNY	0.0%
2018 Q2	346 Thousand CNY	0.0%
2018 FY	-735 Thousand CNY	-160.1%
2018 Q4	-1.08 Million CNY	0.0%
2017 Q2	- CNY	0.0%
2017 Q1	- CNY	0.0%
2017 FY	1.22 Million CNY	0.0%
2017 Q4	- CNY	0.0%
2016 Q4	- CNY	0.0%

Peer Revenue Comparison of Alphamab Oncology

Name	Revenue	Revenue Difference
Uni-Bio Science Group Limited	484.71 Million HKD	54.866%
CK Life Sciences Int'l., (Holdings) Inc.	5.32 Billion HKD	95.89%